Morgan Stanley Call 97.5 GXI 21.0.../ DE000MG2F0S1 /
05/06/2024 11:27:47 | Chg.+0.03 | Bid13:22:45 | Demandez à13:22:45 | Sous-jacent | Prix d'exercice | Date d'expiration | Type d'option |
---|---|---|---|---|---|---|---|
3.03EUR | +1.00% | 3.13 Bid taille: 40,000 |
3.22 Ask la taille: 40,000 |
GERRESHEIMER AG | 97.50 EUR | 21/03/2025 | Call |
GlobeNewswire
13:35
Axsome Therapeutics Settles Sunosi® (solriamfetol) Patent Litigation with Unichem Laboratories
Newsfile Corp
13:30
Appia Begins Uranium Exploration Season with Ground Reconnaissance at "Eastside" Project, Saskatchew...
GlobeNewswire
13:30
Hydreight in Partnership with DSV Global and VS Digital Health Launches Telemedicine Solution That H...
GlobeNewswire
13:30
Ocean Power Technologies Awarded Contract for Immediate Delivery of Unmanned Surface Vehicle to Offs...
GlobeNewswire
13:30
Bread Financial™ to Participate in the Morgan Stanley U.S. Financials, Payments & Commercial Real Es...
GlobeNewswire
13:30
Passage Bio to Present at Goldman Sachs 45th Annual Global Healthcare Conference
GlobeNewswire
13:28
Ollie’s Bargain Outlet Announces Executive Promotions and Appointments as Part of Anticipated Leader...
GlobeNewswire
13:05
Eldorado Gold Announces Election of Directors and Voting Results from Annual Meeting of Shareholders
GlobeNewswire
13:05
Y-mAbs Deepens Radiopharmaceutical Leadership with Appointment of Norman LaFrance, M.D. as Chief Dev...
GlobeNewswire
13:01
Ocean Biomedical (NASDAQ: OCEA) Congratulates Joint Venture Partner, Virion Therapeutics, on Positiv...
GlobeNewswire
13:00
SpringWorks Therapeutics to Participate in the Goldman Sachs 45th Annual Global Healthcare Conferenc...
GlobeNewswire
13:00
G1 Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- La première page
- Retour
- 1
- 2
- 3
- 4
- Suivant
- La dernière page